Will parkinsonism be the ‘third wave’ of the pandemic?
Professor Kevin Barnham and colleagues flag concern for widespread neurodegenerative disorders in the wake of COVID-19
Patients with COVID-19 who report a loss of smell should be monitored for other red flags of neurodegeneration because they might be at risk of Parkinson’s disease, Australian researchers say.
The team from the Florey Institute of Neuroscience and Mental Health in Melbourne, who are investigating the long-term neurological consequences of COVID-19, have issued a ‘call to arms’ this week to prepare for a silent wave of parkinsonism.
